Skip to Content
Merck
CN

G5291

L-α-Glycerophosphorylcholine

≥98%, powder

Synonym(s):

Choline Glycerophosphate, Choline alphoscerate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C8H20NO6P
Molecular Weight:
257.22
NACRES:
NA.83
PubChem Substance ID:
UNSPSC Code:
12352204
EC Number:
248-962-2
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

L-α-Glycerophosphorylcholine, from soybean, ≥98%, powder

biological source

soybean

assay

≥98%

form

powder

solubility

water: 50 mg/mL, clear, colorless to very faintly yellow

storage temp.

−20°C

SMILES string

C[N](C)(C)CCOP(O)(=O)OC[C@@H](O)CO

InChI

1S/C8H21NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3,(H,12,13)

InChI key

XGPKIOAEPQZUED-UHFFFAOYSA-N

General description

L-α-Glycerophosphorylcholine is a phospholipid, which is a derivative of phosphatidylcholine.

Application

L-α-Glycerophosphorylcholine has been used to rescue choline auxotrophy. It has also been used for the synthesis of glycerophospholipids.

Biochem/physiol Actions

Increases inositol phosphate formation.


Storage Class

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial
Moreno MDJM
Clinical Therapeutics, 25(1), 178-193 (2003)
Alzheimer's Disease: Current Research In Early Diagnosis (1990)
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Parnetti L, et al.
Journal of the Neurological Sciences, 257(1-2), 264-269 (2007)



Global Trade Item Number

SKUGTIN
G5291-100MG04061835518142
G5291-10MG04061833057728
G5291-50MG04061833057735